← Leaderboards
Steven Bloembergen
Greenmark Biomedical, Inc.
$1,704,542
Attributed
$1,704,542
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $770.1K · FY2018–20$1M$750K$500K$250K$0
'18
'19
'20
Funding mix
By agency
NIH$1,704,542 · 2
By mechanism
R44$1,475,659 · 1
R43$228,883 · 1
Top collaborators
No co-investigators on record.
Most similar at Greenmark Biomedical, Inc.
Same institution · by research overlap
- Nathan Andrew Jones$429,929
Others in their field
Other Emerging Leaders on “Diagnosis”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$141,100,782
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
Research focus
DiagnosisDiagnostic ProcedureDentalDesignDiagnosticDental EnamelCyclic GmpCostDental ImplantsDentistsDental CariesDental General PracticeAdoptedCessation Of LifeBaseChargeBiomaterial CompatibilityChronic DiseaseAffectDemineralizationDefectDentistryAmylasesDiagnostic Tests
Grant awards (3)
Bioresorbable Nanoparticles for Visual Detection of Early-Stage Dental Caries$705,554
R44 · FY2020 · DE · contact PI
Bioresorbable Nanoparticles for Visual Detection of Early-Stage Dental Caries$770,105
R44 · FY2019 · DE · contact PI
Bioresorbable Nanoparticles for Visual Detection of Early-Stage Dental Caries$228,883
R43 · FY2018 · DE · contact PI